CN106349812A - 一种天然水性油彩墨水 - Google Patents
一种天然水性油彩墨水 Download PDFInfo
- Publication number
- CN106349812A CN106349812A CN201610735660.3A CN201610735660A CN106349812A CN 106349812 A CN106349812 A CN 106349812A CN 201610735660 A CN201610735660 A CN 201610735660A CN 106349812 A CN106349812 A CN 106349812A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- oil
- weight
- quintessence oil
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008239 natural water Substances 0.000 title abstract 2
- 239000003973 paint Substances 0.000 title abstract 2
- 239000000843 powder Substances 0.000 claims abstract description 19
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 11
- 239000011707 mineral Substances 0.000 claims abstract description 11
- 239000003921 oil Substances 0.000 claims description 52
- 239000003814 drug Substances 0.000 claims description 39
- 239000000341 volatile oil Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000003390 Chinese drug Substances 0.000 claims description 8
- 241000241413 Propolis Species 0.000 claims description 8
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 8
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 229940069949 propolis Drugs 0.000 claims description 8
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 7
- 244000162475 Juniperus rigida Species 0.000 claims description 7
- 235000009069 Juniperus rigida Nutrition 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 229910052613 tourmaline Inorganic materials 0.000 claims description 7
- 229940070527 tourmaline Drugs 0.000 claims description 7
- 239000011032 tourmaline Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000007654 immersion Methods 0.000 claims description 6
- 239000000049 pigment Substances 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 241001116389 Aloe Species 0.000 claims description 5
- 244000290333 Vanilla fragrans Species 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- 239000010642 eucalyptus oil Substances 0.000 claims description 5
- 229940044949 eucalyptus oil Drugs 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- 241000242759 Actiniaria Species 0.000 claims description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 4
- 235000010676 Ocimum basilicum Nutrition 0.000 claims description 4
- 240000007926 Ocimum gratissimum Species 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229930185605 Bisphenol Natural products 0.000 claims description 3
- 241000467686 Eschscholzia lobbii Species 0.000 claims description 3
- 235000005135 Micromeria juliana Nutrition 0.000 claims description 3
- 240000002114 Satureja hortensis Species 0.000 claims description 3
- 235000007315 Satureja hortensis Nutrition 0.000 claims description 3
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims description 3
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 238000005202 decontamination Methods 0.000 claims description 3
- 230000003588 decontaminative effect Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 229910000245 dravite Inorganic materials 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229910000244 elbaite Inorganic materials 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000010436 fluorite Substances 0.000 claims description 3
- 229910001676 gahnite Inorganic materials 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000013599 spices Nutrition 0.000 claims description 3
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 22
- 230000002147 killing effect Effects 0.000 abstract description 11
- 241000588724 Escherichia coli Species 0.000 abstract description 6
- 241000191940 Staphylococcus Species 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 239000003205 fragrance Substances 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 5
- 150000002500 ions Chemical class 0.000 abstract description 5
- 241000233866 Fungi Species 0.000 abstract description 4
- 244000052616 bacterial pathogen Species 0.000 abstract description 4
- 241000192125 Firmicutes Species 0.000 abstract description 3
- 241001122767 Theaceae Species 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 239000000976 ink Substances 0.000 description 20
- 231100000614 poison Toxicity 0.000 description 10
- 230000006870 function Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 150000001450 anions Chemical class 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 208000001848 dysentery Diseases 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 241000255925 Diptera Species 0.000 description 5
- 241000194017 Streptococcus Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000009931 harmful effect Effects 0.000 description 5
- 244000045947 parasite Species 0.000 description 5
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 4
- 230000008451 emotion Effects 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000517307 Pediculus humanus Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 244000263375 Vanilla tahitensis Species 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 230000001846 repelling effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 240000004460 Tanacetum coccineum Species 0.000 description 2
- 241000607626 Vibrio cholerae Species 0.000 description 2
- ROVGZAWFACYCSP-MQBLHHJJSA-N [2-methyl-4-oxo-3-[(2z)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1r,3r)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(C\C=C/C=C)C(=O)C1 ROVGZAWFACYCSP-MQBLHHJJSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000002386 air freshener Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- -1 hydroxide group anion Chemical class 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940015367 pyrethrum Drugs 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 241001327638 Cimex lectularius Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 241001215120 Leptospirales Species 0.000 description 1
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 235000006297 Origanum majorana Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 241000404542 Tanacetum Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 235000001667 Vitex agnus castus Nutrition 0.000 description 1
- 244000063464 Vitex agnus-castus Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002096 anti-tetanic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 231100000037 inhalation toxicity test Toxicity 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000196 olfactory nerve Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229910052604 silicate mineral Inorganic materials 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/16—Writing inks
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D11/00—Inks
- C09D11/02—Printing inks
- C09D11/03—Printing inks characterised by features other than the chemical nature of the binder
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Plant Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
一种天然水性油彩墨水,包括活性矿物质粉1.7重量份,不仅可以长期释放空气负离子,净化空气,利于人体健康;还对葡萄球菌、大肠杆菌、革兰阳性细菌等多种病菌和真菌有一定的抑制、杀灭作用;同时气味芳香,清新怡神,舒缓压力,使用后可留下持久的香气,具有提神醒脑、消除疲劳的保健功效,适用于各个年龄人群,具有非常广泛的应用前景。
Description
本申请是申请日2016年8月25日提交的申请号为2016107229716,发明名称为“一种天然水性油彩墨水”的中国发明专利申请的分案申请。
技术领域
本发明涉及一种墨水,特别涉及一种天然水性油彩墨水。
背景技术
墨水可用于日常办公或纺织印刷领域,但传统的一般墨水不具有提神和产生负离子等保健效果,使用者在长时使用用产生倦怠感,由于传统墨水的功能单一,已不能满足人们的多元需求。
发明内容
针对现有技术存在的不足,本发明为墨水的使用者提供一种气味清新,具有提神作用及负离子保健效果的墨水,它不仅可以长期释放空气负离子,净化空气,利于人体健康;还对葡萄球菌、大肠杆菌、革兰阳性细菌等多种病菌和真菌有一定的抑制、杀灭作用;同时气味芳香,清新怡神,舒缓压力,还可驱赶蚊虫,不会对人体产生不良影响,具有非常广泛的应用前景。
本发明的目的是通过如下技术方案实现的:
一种天然水性油彩墨水,其特征在于:由下列组份按照重量份数组成:颜料色浆23重量份,双酚A19重量份,甘油4.5重量份,无水硫酸钠2.3重量份,三乙醇胺2.7重量份,三乙胺3.3重量份,丙酮3.6重量份,双硫代氨基甲酸酯0.25重量份,活性矿物质粉1.7重量份,表面活性剂复配物1.2重量份,缓释剂0.55重量份,中药精油3.85重量份,去离子水62重量份,所述颜料色浆的平均粒径为75nm,所述的活性矿物质粉为锗石、萤石、电气石、锌尖晶石按重量比2.5:3:3.7:2的混合物,其中电气石为镁电气石和锂电气石按重量比5:3的混合物,所述活性矿物质粉的粒径≤13μm,其中所述的中药精油通过如下步骤制备而成,
S1、取打破碗花花35重量份洗净,自然晾干,然后置于90℃炒锅中炒至有香味逸出,然后喷淋去离子水17重量份,置于恒温烘箱中60℃以下烘干,含水量≤6.5%;
S2、将贯众13重量洗净,放入盐水中浸泡3.5小时,盐水量为所浸泡药料质量的3.7倍,放入锅中蒸透,取出,晾干,盐水的浓度为27%;
S3、将丁香罗勒0.75重量份,百部13重量份,芦荟1重量份,白芍药1重量份,麝香0.6-18重量份去杂质,与步骤S1和S2所制原料药一起投入超微粉碎机中粉碎至60目,制得原料药粉末,备用;
S4、将步骤S3中制得的原料药粉末投入超临界二氧化碳萃取装置的萃取釜中,调节萃取压力27.65MPa,萃取温度45.10℃,二氧化碳流量为0.6m3/h,动态萃取2.5h,直接在分离釜出口用三角瓶收集挥发油A,备用;
S5、将大青叶12重量份,柴胡1重量份,黄柏1重量份,连翘1重量份洗净烘干,一起投入超微粉碎机中粉碎至70目,然后加去离子水浸泡6小时,加水量为所浸泡原料药质量的6.5倍,搅拌分散调匀,制得中药混合物,备用;
S6、将步骤S5制得的中药混合物于80℃煎煮2小时,收集蒸馏液,并加入乙醚萃取,蒸馏液与乙醚的体积比为2:1,取上层油相,然后加无水硫酸钠干燥,即制得挥发油B,备用;
S7、将步骤S4和S6所制挥发油A和挥发油B混合调匀制得混合油,再边搅拌边依次加入香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油,充分搅拌35分钟,静置30分钟,充分搅拌调匀,过滤除杂,即得中药精油,其中,所述混合油与香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油的质量比为1.3:0.4:0.75:0.6:0.5:0.3。
在一较佳实施例中,在步骤S3的原料药粉末中还包含有牛至油1.3重量份和白花除虫菊1.5重量份。
在一较佳实施例中,在步骤S5的中药混合物中还包含有冰片0.6重量份和荷叶0.4重量份。
在一较佳实施例中,在步骤S7的中药精油中还包含有桉树油0.3重量份。
本发明所涉及的设备、原料及方法,均为本行业惯常使用的设备、原料及方法,在此不再赘述。
其中各精油组分必须和表面活性剂、缓释剂充分混合,以达到缓释效果,各精油及负离子天然矿物质粉的添加量一定要适量,不仅抗菌杀菌,还能安定情绪,所以对失常的心理状态有正面的效果,能净化、安抚心灵,可减轻愤怒和筋疲力竭的感觉,使人可以心平气和地面对生活,因为它能平衡中枢神经,所以对惊慌和沮丧的状态很有帮助,也有明显的平静与舒缓功能,对失眠者有相当好的舒放与精神抚慰,对于安抚躁进或心情不稳的脾气有相当好的效果,可提高工作效率。
本发明参考现代中药药理研究,从现有中药的药物筛选和反复验证,充分发挥各组重量份协同作用,其中各中药组分简介如下。
打破碗花花:①《陕西中草药》:“苦,凉,有小毒。”②《四川常用中草药》:“苦辛,温,有小毒。” 解毒,排脓生肌,消肿散瘀,具有杀蛆虫、孑孓,化积,消肿,散瘀,治顽癣,秃疮,疟疾,小儿疳积,痢疾,痈疖疮肿,瘰疬,跌打损伤。
贯众:苦微寒,归肝脾经,有小毒。杀虫,清热解毒,止血。
丁香罗勒:辛,温,具有驱蚊,发汗解表,祛风利湿,散瘀止痛的功效。
百部:可驱除蚊虫,抗病原微生物作用,对乙型溶血性链球菌、脑膜炎球菌、金黄色葡萄球菌、白色葡萄球菌、伤寒杆菌、肺炎杆菌、鼠疫杆菌、炭疽杆菌等多种致病真菌有一定的抑制作用,其水浸液对蚊蝇幼虫、头虱、衣虱及臭虫等均有杀灭作用。
芦荟:《本草经疏》:芦荟,寒能除热,苦能泄热燥湿,苦能杀虫,至苦至寒,故为除热杀虫之要药。其主热风烦闷,胸胁间热气,明目,镇心,小儿癫痫凉风,疗五疳,杀三虫者,热则生风,热能使人烦闷,热除则风热烦闷及胸膈间热气自解。
白芍药:其中芍药甙有抗菌、解热、抗炎、增加冠状动脉流量、改善心肌营养血流、扩张血管、对抗急性心肌缺血、抑制血小板聚集、镇静、镇痛、解痉、抗溃疡、调节血糖的作用。白芍煎剂能抑制痢疾杆菌、肺炎链球菌、大肠杆菌、伤寒杆菌、溶血性链球菌、绿脓杆菌等。
麝香: 具有开窍,辟秽,通络,散瘀的功效;治中风,痰厥,惊痫,中恶烦闷,心腹暴痛,癥瘕癖积,跌打损伤,痈疽肿毒。《本经》:主辟恶气,温疟,痫痉,去三虫。
大青叶:对金黄色葡萄球菌、甲型链球菌、脑膜炎双球菌、肺炎链球菌、卡他球菌、伤寒杆菌、大肠杆菌、流感杆菌、白喉杆菌及痢疾杆菌有一定抑制作用;大青叶对乙型脑炎病毒、腮腺炎病毒、流感病毒等也有抑制作用.此外大青叶有杀灭钩端螺旋体的作用。
柴胡: 和解少阳,舒肝和胃,升阳举陷。治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂,热入血室。
黄柏:对金黄色葡萄球菌、肺炎球菌、白喉杆菌、草绿色链球菌、痢疾杆菌(宋内氏除外)、溶血性链球菌、脑膜炎球菌、霍乱弧菌、炭疽杆菌均有效或有较强的抑制作用;对枯草杆菌、百日咳杆菌、破伤风杆菌亦有抑制作用。
连翘:清热解毒,消肿散结,疏散风热,有“疮家圣药”之称,可抑制伤寒杆菌、副伤寒杆菌、大肠杆菌、痢疾杆菌、白喉杆菌及霍乱弧菌、葡萄球菌、链球菌等。
香子兰精油: 香子兰有特殊的香气,具有抗疲劳和心情郁闷、助荷尔蒙分泌、舒缓焦虑及改善失眠等功效。具有强心、补脑、健胃、解毒、驱风、增强肌肉力量的功效,作芳香型神经系统兴奋剂和补肾药,用来治疗癔病、忧郁症 、阳痿、虚热和风湿病。
蜂胶精油:能抗菌抗病毒功效,近代研究证明,蜂胶所含有的丰富而独特的生物活性物质,使其具有抗菌、消炎、止痒、抗氧化、增强免疫等多种功能。
杜松精油:具有净化空气、防蚊虫虰咬、抗菌、抗风湿、抗痉挛的功效,也具有镇定提神、激励情绪、净化思绪及释放心灵的功能,能够让人身心舒松,也具有催情的效果;另外,它排毒的功能十分出名,它能排出堆积的毒素,净化肠道黏膜。
茉莉精油:具有明显的放松效果,可以振奋精神,提升自信心,强力的抗忧郁能力可使人精神愉快,忘记烦恼。同时安抚神经、产生正面的感受,建立一种自信,有乐观和精神欢快的感觉,有助于恢复精力,它同时具有松弛和温暖情绪的功能。
玫瑰精油:具有抗菌、杀菌、催情、镇静、补身等功效,具有抚平情绪,提振心情,舒缓神经紧张和压力,能使女人对自我产生积极正面的感受,其天然芬芳经嗅觉神经进入人体后,能使人精神愉悦、惬意,缓解焦虑、抑郁、压力,帮助睡眠,促进新陈代谢、血液循环的作用。
牛至油:唇形科牛至属植物牛至ORIGZNUM VUL-GAREL.的全草,又名止痢草、野荆芥等地符名,具有清热、化湿、祛暑、解表、理气极强的杀菌、抑菌作用,从牛至中提取的挥发油,对31种常见致肠炎细菌和福氏痢疾杆菌,是最具有广谱抗菌的纯正中药药物添加剂。
白花除虫菊:菊蒿属(Tanacetum)数种植物的统称,燥湿杀虫、 灭杀阴虱、头虱、体虱、跳蚤、除蚊杀虫的功效。
冰片:辛,苦,凉。具有开窍醒神,清热散毒,明目退翳。主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。
荷叶:为睡莲科植物莲的叶,有清热解毒、凉血、止血的作用。 有清暑利湿、升发清阳、凉血止血等功效。
桉树油:最常见和用途最广泛的精油之一,具有良好的保健作用,帮助集中注意力。能够有效缓解鼻窦感染,流感,支气管炎,伤风鼻塞和其他呼吸系统疾病。具有良好的抗菌和杀菌特性,在一些特定食品中,桉树油还作为香料成分。在旅行时携带这种精油,可以有效抵御蚊叮虫咬,治疗皮肤疹子。是良好的驱蚊剂。与水混合可以成为一种简单有效的消毒剂。
本发明的有益效果:
本发明为使用者提供一种气味清新,具有提神作用及负离子保健功效的墨水,它不仅可以长期释放空气负离子,净化空气,利于人体健康;还对葡萄球菌、大肠杆菌、革兰阳性细菌等多种病菌和真菌有一定的抑制、杀灭作用;同时气味芳香,清新怡神,舒缓压力,还可驱赶蚊虫,不会对人体产生不良影响,适用于各个年龄人群,其在适量添加其它功能组分后仍能够保持原有的效果和质量。
1、电气石是一种硅酸盐矿物,其化学式为Na(Mg,Fe,Mn,Li,Al)3Al6(Si6O18)(Bo3)3(OH,F)4,它与水分子接触在静电场作用下,便可将水分子电离成氢离子(H+)和氢氧根离子(OH-),氢氧根离子与水分子结合形成碱性羟基负离子(H2O•OH-),即为“空气负离子”,目前科学研究证明:负离子不仅能促成人体合成和储存维生素,强化和激活人体的生理活动,对人体及其他生物的生命活动有着十分重要的影响,被称为″空气维生素″。负离子有效吸附室内有害物质,如甲醛、甲苯等建筑装修有害物质,不仅自身不增加污染,而且清洁净化室内空气,从根本上消除建筑装修综合症,保障人体健康不受影响。
2、本发明中含有的中药成分,不仅对葡萄球菌、结核杆菌、绿脓杆菌、革兰阴性细菌和革兰阳性细菌等多种病菌和真菌有一定的抑制、杀灭作用;同时气味芳香,性质温和,清新怡神,助荷尔蒙分泌,舒缓焦虑的功效,同时也具有一定的驱蚊虫效果,更为关键的是,长期使用本发明不会对人体产生不良影响,适用于各个年龄人群,具有非常广泛的应用前景。
具体实施方式
实施例。
一种天然水性油彩墨水,其特征在于:由下列组份按照重量份数组成:颜料色浆23重量份,双酚A19重量份,甘油4.5重量份,无水硫酸钠2.3重量份,三乙醇胺2.7重量份,三乙胺3.3重量份,丙酮3.6重量份,双硫代氨基甲酸酯0.25重量份,活性矿物质粉1.7重量份,表面活性剂复配物1.2重量份,缓释剂0.55重量份,中药精油3.85重量份,去离子水62重量份,所述颜料色浆的平均粒径为75nm,所述的活性矿物质粉为锗石、萤石、电气石、锌尖晶石按重量比2.5:3:3.7:2的混合物,其中电气石为镁电气石和锂电气石按重量比5:3的混合物,所述活性矿物质粉的粒径≤13μm,其中所述的中药精油通过如下步骤制备而成,
S1、取打破碗花花35重量份洗净,自然晾干,然后置于90℃炒锅中炒至有香味逸出,然后喷淋去离子水17重量份,置于恒温烘箱中60℃以下烘干,含水量≤6.5%;
S2、将贯众13重量洗净,放入盐水中浸泡3.5小时,盐水量为所浸泡药料质量的3.7倍,放入锅中蒸透,取出,晾干,盐水的浓度为27%;
S3、将丁香罗勒0.75重量份,百部13重量份,芦荟1重量份,白芍药1重量份,麝香0.6-18重量份去杂质,与步骤S1和S2所制原料药一起投入超微粉碎机中粉碎至60目,制得原料药粉末,备用;
S4、将步骤S3中制得的原料药粉末投入超临界二氧化碳萃取装置的萃取釜中,调节萃取压力27.65MPa,萃取温度45.10℃,二氧化碳流量为0.6m3/h,动态萃取2.5h,直接在分离釜出口用三角瓶收集挥发油A,备用;
S5、将大青叶12重量份,柴胡1重量份,黄柏1重量份,连翘1重量份洗净烘干,一起投入超微粉碎机中粉碎至70目,然后加去离子水浸泡6小时,加水量为所浸泡原料药质量的6.5倍,搅拌分散调匀,制得中药混合物,备用;
S6、将步骤S5制得的中药混合物于80℃煎煮2小时,收集蒸馏液,并加入乙醚萃取,蒸馏液与乙醚的体积比为2:1,取上层油相,然后加无水硫酸钠干燥,即制得挥发油B,备用;
S7、将步骤S4和S6所制挥发油A和挥发油B混合调匀制得混合油,再边搅拌边依次加入香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油,充分搅拌35分钟,静置30分钟,充分搅拌调匀,过滤除杂,即得中药精油,其中,所述混合油与香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油的质量比为1.3:0.4:0.75:0.6:0.5:0.3。
在一较佳实施例中,在步骤S3的原料药粉末中还包含有牛至油1.3重量份和白花除虫菊1.5重量份。
在一较佳实施例中,在步骤S5的中药混合物中还包含有冰片0.6重量份和荷叶0.4重量份。
在一较佳实施例中,在步骤S7的中药精油中还包含有桉树油0.3重量份。
使用空气离子静态测试法测试该上述实施例中的墨水,负离子释放量在430-650个/ m3,而且持续释放空气负离子,更有利于长期净化空气,达到人们健康的基本要求。
对照例。
色素炭黑20g,苯酚11g,甘油4g,苯并三氮唑3g,三乙醇胺1g,三乙胺3g,碳酸氢钠5g,聚氧乙烯基醚类非离子型氟碳表面活性剂1.5g,缓释剂0.4g,甜马郁兰精油0.6g,小麦芽精油0.5g,薰衣草精油0.5g,白芍药精油0.4g,丝柏精油0. 4g,尤加利精油0.4g,艾叶精油0. 4g,薄荷精油0.4g,去离子水75g。
使用空气离子静态测试法测试该上述对照例中的墨水,负离子释放量在0个/ m3,不具有释放空气负离子的功能。
(1)对所制得的中药精油进行急性毒性试验,结果如下:
①小鼠口服急性毒性试验:小鼠口服中药精油的LD50 为383.55g/kg,95%的可信限为294.68g/kg~ 499.31g/kg。而空气清新剂的毒性判定标准是:小鼠口服急毒LD50 ≥ 5g/kg,判定为无毒。本中药精油的LD50 高于无毒标准的76 倍,因此判定为无毒。
②小鼠急性吸入毒性试验:小鼠急性吸入中药精油的LC50 为24863.99g/m3,95%的可信限为16837.34g/m3 ~ 33387.46g/m3。而空气清新剂的毒性判定标准是:小鼠急性吸入(2h)LC50 > 10000mg/m3,属实际无毒级。本中药精油的LC50 高于无毒标准的2486倍,因此判定为无毒。
所制得的中药精油经检验,其香气、色泽、折光指数、相对密度、含砷量、重金属含量、pH 值均符合国家标准的要求。
(2)检验上述油墨负离子释放量结果如表1:
(3)对改善精神状态的测试。
主要方法是墨水使用志愿者实验,招募60人,分别使用上述2种实施例中的墨水,通过SCL-90问卷(即《症状自评量表-SCL90》,是世界上最著名的心理健康测试量表之一),通过连续1周的使用跟踪,来判定本发明在提神方面的实际功效作用,其中3人无感受;7人感受一般;1人认为本品对于提神作用无效;有49人反馈本品具有较好的提神效果,可以使人注意力集中,有效率为81.67%。
(4)驱蚊效果测试。
依据现有技术中的普通墨水与上述实施例中墨水的驱蚊效果进行对比测试,测试数据见表2。
结论:本发明实施例中的墨水具有一定的驱蚊效果。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,对于所属领域的普通技术人员来说,在上述说明的基础上还可以做出其它不同形式的变化或变动,这里无需也无法对所有的实施方式予以穷举,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,仍包含在本发明的保护范围之内。
Claims (1)
1.一种天然水性油彩墨水,其特征在于:由下列组份按照重量份数组成:颜料色浆23重量份,双酚A19重量份,甘油4.5重量份,无水硫酸钠2.3重量份,三乙醇胺2.7重量份,三乙胺3.3重量份,丙酮3.6重量份,双硫代氨基甲酸酯0.25重量份,活性矿物质粉1.7重量份,表面活性剂复配物1.2重量份,缓释剂0.55重量份,中药精油3.85重量份,去离子水62重量份,所述颜料色浆的平均粒径为75nm,所述的活性矿物质粉为锗石、萤石、电气石、锌尖晶石按重量比2.5:3:3.7:2的混合物,其中电气石为镁电气石和锂电气石按重量比5:3的混合物,所述活性矿物质粉的粒径≤13μm,其中所述的中药精油通过如下步骤制备而成,
S1、取打破碗花花35重量份洗净,自然晾干,然后置于90℃炒锅中炒至有香味逸出,然后喷淋去离子水17重量份,置于恒温烘箱中60℃以下烘干,含水量≤6.5%;
S2、将贯众13重量洗净,放入盐水中浸泡3.5小时,盐水量为所浸泡药料质量的3.7倍,放入锅中蒸透,取出,晾干,盐水的浓度为27%;
S3、将丁香罗勒0.75重量份,百部13重量份,芦荟1重量份,白芍药1重量份,麝香0.6-18重量份,牛至油1.3重量份和白花除虫菊1.5重量份去杂质,与步骤S1和S2所制原料药一起投入超微粉碎机中粉碎至60目,制得原料药粉末,备用;
S4、将步骤S3中制得的原料药粉末投入超临界二氧化碳萃取装置的萃取釜中,调节萃取压力27.65MPa,萃取温度45.10℃,二氧化碳流量为0.6m3/h,动态萃取2.5h,直接在分离釜出口用三角瓶收集挥发油A,备用;
S5、将大青叶12重量份,柴胡1重量份,黄柏1重量份,连翘1重量份,冰片0.6重量份和荷叶0.4重量份洗净烘干,一起投入超微粉碎机中粉碎至70目,然后加去离子水浸泡6小时,加水量为所浸泡原料药质量的6.5倍,搅拌分散调匀,制得中药混合物,备用;
S6、将步骤S5制得的中药混合物于80℃煎煮2小时,收集蒸馏液,并加入乙醚萃取,蒸馏液与乙醚的体积比为2:1,取上层油相,然后加无水硫酸钠干燥,即制得挥发油B,备用;
S7、将步骤S4和S6所制挥发油A和挥发油B混合调匀制得混合油,再边搅拌边依次加入香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油,充分搅拌35分钟,静置30分钟,充分搅拌调匀,过滤除杂,即得中药精油,其中,所述混合油与香子兰精油、蜂胶精油、杜松精油、茉莉精油和玫瑰精油的质量比为1.3:0.4:0.75:0.6:0.5:0.3,所述中药精油中还包含有桉树油0.3重量份。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610093675.4A CN105504986A (zh) | 2016-02-19 | 2016-02-19 | 一种天然水性油彩墨水 |
CN2016100936754 | 2016-02-19 | ||
CN201610722971.6A CN106318037A (zh) | 2016-02-19 | 2016-08-25 | 一种天然水性油彩墨水 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610722971.6A Division CN106318037A (zh) | 2016-02-19 | 2016-08-25 | 一种天然水性油彩墨水 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106349812A true CN106349812A (zh) | 2017-01-25 |
Family
ID=55713305
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610093675.4A Pending CN105504986A (zh) | 2016-02-19 | 2016-02-19 | 一种天然水性油彩墨水 |
CN201610722971.6A Pending CN106318037A (zh) | 2016-02-19 | 2016-08-25 | 一种天然水性油彩墨水 |
CN201610735660.3A Pending CN106349812A (zh) | 2016-02-19 | 2016-08-25 | 一种天然水性油彩墨水 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610093675.4A Pending CN105504986A (zh) | 2016-02-19 | 2016-02-19 | 一种天然水性油彩墨水 |
CN201610722971.6A Pending CN106318037A (zh) | 2016-02-19 | 2016-08-25 | 一种天然水性油彩墨水 |
Country Status (1)
Country | Link |
---|---|
CN (3) | CN105504986A (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106280692A (zh) * | 2016-08-15 | 2017-01-04 | 安徽明诚塑业有限公司 | 一种环保水性油墨及其制备方法 |
-
2016
- 2016-02-19 CN CN201610093675.4A patent/CN105504986A/zh active Pending
- 2016-08-25 CN CN201610722971.6A patent/CN106318037A/zh active Pending
- 2016-08-25 CN CN201610735660.3A patent/CN106349812A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CN106318037A (zh) | 2017-01-11 |
CN105504986A (zh) | 2016-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105504966B (zh) | 一种平版胶印油墨 | |
CN106318038A (zh) | 一种水性uv油墨 | |
CN106310323A (zh) | 一种植物精油空气清新剂 | |
CN104921568B (zh) | 一种广谱抗菌型负离子地毯 | |
CN106349801A (zh) | 一种复配活性矿物质环保油墨 | |
CN106380931A (zh) | 环保水性油墨 | |
CN105708763A (zh) | 一种含有艾叶提取物的花露水及其制备方法 | |
CN106349812A (zh) | 一种天然水性油彩墨水 | |
CN104186577A (zh) | 一种含龙涎香提取物的缓释型电热蚊香液及制备方法 | |
CN106336722A (zh) | 一种改良型印刷油墨 | |
CN106336735A (zh) | 一种遮盖型纺织品喷墨印花颜料油墨 | |
CN106189513A (zh) | 一种遮盖型纺织品喷墨印花颜料油墨 | |
CN106336731A (zh) | 一种墨汁 | |
CN106336732A (zh) | 一种彩色墨汁组合物 | |
CN106147393A (zh) | 一种教学板用彩色墨汁 | |
CN106366760A (zh) | 水性书写墨水组合物 | |
CN106189516A (zh) | 一种新型彩色喷墨打印墨水 | |
CN104924937A (zh) | 含金银花提取物的新型汽车座椅靠枕及应用该靠枕的汽车 | |
CN104186574A (zh) | 一种含有灵香草芳香的电热液体蚊香及制备方法 | |
CN106280706A (zh) | 一种新型彩色喷墨打印墨水 | |
CN104986070A (zh) | 一种薰衣草保健型汽车颈枕及应用该颈枕的汽车座椅 | |
CN108102461A (zh) | 一种书法用墨汁 | |
CN104186575A (zh) | 一种含香子兰提取物的提神醒脑电热液体蚊香及制备方法 | |
CN106189845A (zh) | 一种纳米荧光粉复合材料环保led灯罩的制备工艺 | |
CN105620382A (zh) | 具有负离子分块嵌饰板的汽车左后门内装饰板总成 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170125 |